Proactiveinvestors USA & Canada Ergomed PLC https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Ergomed PLC RSS feed en Mon, 27 Jan 2020 16:48:24 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Ergomed jumps following acquisition drug safety firm of Ashfield Pharmacovigilance https://www.proactiveinvestors.com/companies/news/910464/ergomed-jumps-following-acquisition-drug-safety-firm-of-ashfield-pharmacovigilance-910464.html Mon, 13 Jan 2020 13:13:00 -0500 https://www.proactiveinvestors.com/companies/news/910464/ergomed-jumps-following-acquisition-drug-safety-firm-of-ashfield-pharmacovigilance-910464.html Ergomed nets significant new acquisition https://www.proactiveinvestors.com/companies/news/910456/ergomed-nets-significant-new-acquisition-910456.html Mon, 13 Jan 2020 11:54:00 -0500 https://www.proactiveinvestors.com/companies/news/910456/ergomed-nets-significant-new-acquisition-910456.html Ergomed PLC reports strong order book and significant new business wins https://www.proactiveinvestors.com/companies/news/903437/ergomed-plc-reports-strong-order-book-and-significant-new-business-wins-903437.html Wed, 25 Sep 2019 08:30:00 -0400 https://www.proactiveinvestors.com/companies/news/903437/ergomed-plc-reports-strong-order-book-and-significant-new-business-wins-903437.html Ergomed hails a strong first-half as order book continues to grow https://www.proactiveinvestors.com/companies/news/903418/ergomed-hails-a-strong-first-half-as-order-book-continues-to-grow-903418.html Wed, 25 Sep 2019 06:51:00 -0400 https://www.proactiveinvestors.com/companies/news/903418/ergomed-hails-a-strong-first-half-as-order-book-continues-to-grow-903418.html Ergomed in robust shape as it continues to perform 'above expectations' https://www.proactiveinvestors.com/companies/news/314185/ergomed-in-robust-shape-as-it-continues-to-perform--above-expectations--14185.html Wed, 24 Jul 2019 08:33:00 -0400 https://www.proactiveinvestors.com/companies/news/314185/ergomed-in-robust-shape-as-it-continues-to-perform--above-expectations--14185.html Ergomed's cost-cutting programme to yield £4mln in savings each year https://www.proactiveinvestors.com/companies/news/205193/ergomed-s-cost-cutting-programme-to-yield-4mln-in-savings-each-year-205193.html Wed, 19 Sep 2018 11:41:00 -0400 https://www.proactiveinvestors.com/companies/news/205193/ergomed-s-cost-cutting-programme-to-yield-4mln-in-savings-each-year-205193.html Ergomed names Stuart Jackson as the group’s chief financial officer with immediate effect https://www.proactiveinvestors.com/companies/news/199942/ergomed-names-stuart-jackson-as-the-groups-chief-financial-officer-with-immediate-effect-199942.html Mon, 02 Jul 2018 08:12:00 -0400 https://www.proactiveinvestors.com/companies/news/199942/ergomed-names-stuart-jackson-as-the-groups-chief-financial-officer-with-immediate-effect-199942.html Ergomed revenue delay leads to Numis downgrade https://www.proactiveinvestors.com/companies/news/199777/ergomed-revenue-delay-leads-to-numis-downgrade-199777.html Thu, 28 Jun 2018 10:10:00 -0400 https://www.proactiveinvestors.com/companies/news/199777/ergomed-revenue-delay-leads-to-numis-downgrade-199777.html Ergomed brings in new hire to bolster PrimeVigilance service offering https://www.proactiveinvestors.com/companies/news/197690/ergomed-brings-in-new-hire-to-bolster-primevigilance-service-offering-197690.html Fri, 25 May 2018 09:30:00 -0400 https://www.proactiveinvestors.com/companies/news/197690/ergomed-brings-in-new-hire-to-bolster-primevigilance-service-offering-197690.html Ergomed sees strong rise in backlog of contracted revenue https://www.proactiveinvestors.com/companies/news/194711/ergomed-sees-strong-rise-in-backlog-of-contracted-revenue-194711.html Wed, 11 Apr 2018 06:48:00 -0400 https://www.proactiveinvestors.com/companies/news/194711/ergomed-sees-strong-rise-in-backlog-of-contracted-revenue-194711.html Ergomed's year of exceptional growth and clinical success overshadowed by foreign exchange adjustments https://www.proactiveinvestors.com/companies/news/192588/ergomed-s-year-of-exceptional-growth-and-clinical-success-overshadowed-by-foreign-exchange-adjustments-192588.html Mon, 05 Mar 2018 08:18:00 -0500 https://www.proactiveinvestors.com/companies/news/192588/ergomed-s-year-of-exceptional-growth-and-clinical-success-overshadowed-by-foreign-exchange-adjustments-192588.html Ergomed raises £3.9mln as it looks to develop its PrimeVigilance business https://www.proactiveinvestors.com/companies/news/190979/ergomed-raises-39mln-as-it-looks-to-develop-its-primevigilance-business-190979.html Thu, 01 Feb 2018 08:36:00 -0500 https://www.proactiveinvestors.com/companies/news/190979/ergomed-raises-39mln-as-it-looks-to-develop-its-primevigilance-business-190979.html Ergomed update underlines the potential of the company's PrimeVigilance unit https://www.proactiveinvestors.com/companies/news/190625/ergomed-update-underlines-the-potential-of-the-company-s-primevigilance-unit-190625.html Thu, 25 Jan 2018 11:04:00 -0500 https://www.proactiveinvestors.com/companies/news/190625/ergomed-update-underlines-the-potential-of-the-company-s-primevigilance-unit-190625.html Ergomed ready to kick on after a strong year https://www.proactiveinvestors.com/companies/news/190596/ergomed-ready-to-kick-on-after-a-strong-year-190596.html Thu, 25 Jan 2018 10:41:00 -0500 https://www.proactiveinvestors.com/companies/news/190596/ergomed-ready-to-kick-on-after-a-strong-year-190596.html Ergomed's finance chief appointed chief executive; welcomes new COO https://www.proactiveinvestors.com/companies/news/188864/ergomed-s-finance-chief-appointed-chief-executive-welcomes-new-coo-188864.html Fri, 15 Dec 2017 15:15:00 -0500 https://www.proactiveinvestors.com/companies/news/188864/ergomed-s-finance-chief-appointed-chief-executive-welcomes-new-coo-188864.html Ergomed Plc adds to co-development pipeline with Allergy Therapeutics deal https://www.proactiveinvestors.com/companies/news/308537/ergomed-plc-adds-to-co-development-pipeline-with-allergy-therapeutics-deal-8537.html Wed, 13 Dec 2017 15:25:00 -0500 https://www.proactiveinvestors.com/companies/news/308537/ergomed-plc-adds-to-co-development-pipeline-with-allergy-therapeutics-deal-8537.html Ergomed to present at the International Society of Pharmacovigilance's Intelligent Automation https://www.proactiveinvestors.com/companies/news/188176/ergomed-to-present-at-the-international-society-of-pharmacovigilance-s-intelligent-automation-188176.html Mon, 04 Dec 2017 08:09:00 -0500 https://www.proactiveinvestors.com/companies/news/188176/ergomed-to-present-at-the-international-society-of-pharmacovigilance-s-intelligent-automation-188176.html Ergomed hopes to have PeproStat on the market by 2020 as it sails through Phase II trials https://www.proactiveinvestors.com/companies/news/186006/ergomed-hopes-to-have-peprostat-on-the-market-by-2020-as-it-sails-through-phase-ii-trials-186006.html Mon, 23 Oct 2017 13:58:00 -0400 https://www.proactiveinvestors.com/companies/news/186006/ergomed-hopes-to-have-peprostat-on-the-market-by-2020-as-it-sails-through-phase-ii-trials-186006.html Ergomed's PeproStat successfully completes Phase II clinical trial https://www.proactiveinvestors.com/companies/news/308273/ergomed-s-peprostat-successfully-completes-phase-ii-clinical-trial-8273.html Mon, 23 Oct 2017 11:20:00 -0400 https://www.proactiveinvestors.com/companies/news/308273/ergomed-s-peprostat-successfully-completes-phase-ii-clinical-trial-8273.html Ergomed PSR acquisition seen as a “good fit” https://www.proactiveinvestors.com/companies/news/185193/ergomed-psr-acquisition-seen-as-a-good-fit-185193.html Fri, 06 Oct 2017 10:56:00 -0400 https://www.proactiveinvestors.com/companies/news/185193/ergomed-psr-acquisition-seen-as-a-good-fit-185193.html Ergomed unveils €5.7mln acquisition of Dutch-based PSR Group, part-funded by £2.9mln placing https://www.proactiveinvestors.com/companies/news/184737/ergomed-unveils-57mln-acquisition-of-dutch-based-psr-group-part-funded-by-29mln-placing-184737.html Thu, 28 Sep 2017 15:05:00 -0400 https://www.proactiveinvestors.com/companies/news/184737/ergomed-unveils-57mln-acquisition-of-dutch-based-psr-group-part-funded-by-29mln-placing-184737.html Ergomed develops in orphan drug space with PSR Group acquisition https://www.proactiveinvestors.com/companies/news/308161/ergomed-develops-in-orphan-drug-space-with-psr-group-acquisition-8161.html Thu, 28 Sep 2017 14:46:00 -0400 https://www.proactiveinvestors.com/companies/news/308161/ergomed-develops-in-orphan-drug-space-with-psr-group-acquisition-8161.html Ergomed signs first commercialisation deal for its blood coagulant products https://www.proactiveinvestors.com/companies/news/184643/ergomed-signs-first-commercialisation-deal-for-its-blood-coagulant-products-184643.html Wed, 27 Sep 2017 06:26:00 -0400 https://www.proactiveinvestors.com/companies/news/184643/ergomed-signs-first-commercialisation-deal-for-its-blood-coagulant-products-184643.html Ergomed pleased with top-line growth in "solid first half" https://www.proactiveinvestors.com/companies/news/184134/ergomed-pleased-with-top-line-growth-in-solid-first-half--184134.html Mon, 18 Sep 2017 08:53:00 -0400 https://www.proactiveinvestors.com/companies/news/184134/ergomed-pleased-with-top-line-growth-in-solid-first-half--184134.html FDA gives Ergomed’s partner green light to resume phase III cancer study https://www.proactiveinvestors.com/companies/news/182399/fda-gives-ergomeds-partner-green-light-to-resume-phase-iii-cancer-study-182399.html Mon, 14 Aug 2017 13:05:00 -0400 https://www.proactiveinvestors.com/companies/news/182399/fda-gives-ergomeds-partner-green-light-to-resume-phase-iii-cancer-study-182399.html Ergomed completes recruitment for phase IIb study of PeproStat ahead of schedule https://www.proactiveinvestors.com/companies/news/181323/ergomed-completes-recruitment-for-phase-iib-study-of-peprostat-ahead-of-schedule Mon, 24 Jul 2017 06:35:00 -0400 https://www.proactiveinvestors.com/companies/news/181323/ergomed-completes-recruitment-for-phase-iib-study-of-peprostat-ahead-of-schedule Interest in Ergomed's blood thickener 'significant' - CEO Miroslav Reljanovic https://www.proactiveinvestors.com/companies/news/307669/interest-in-ergomed-s-blood-thickener-significant-ceo-miroslav-reljanovic-7669.html Wed, 21 Jun 2017 09:29:00 -0400 https://www.proactiveinvestors.com/companies/news/307669/interest-in-ergomed-s-blood-thickener-significant-ceo-miroslav-reljanovic-7669.html Ergomed trial of blood thickener on the fast-track https://www.proactiveinvestors.com/companies/news/179592/ergomed-trial-of-blood-thickener-on-the-fast-track-179592.html Wed, 21 Jun 2017 06:28:00 -0400 https://www.proactiveinvestors.com/companies/news/179592/ergomed-trial-of-blood-thickener-on-the-fast-track-179592.html Ergomed appoints new chief executive https://www.proactiveinvestors.com/companies/news/179354/ergomed-appoints-new-chief-executive-179354.html Fri, 16 Jun 2017 06:26:00 -0400 https://www.proactiveinvestors.com/companies/news/179354/ergomed-appoints-new-chief-executive-179354.html Ergomed's hybrid strategy gives it plenty of ammo https://www.proactiveinvestors.com/companies/news/124711/ergomed-s-hybrid-strategy-gives-it-plenty-of-ammo-124711.html Wed, 03 May 2017 11:45:00 -0400 https://www.proactiveinvestors.com/companies/news/124711/ergomed-s-hybrid-strategy-gives-it-plenty-of-ammo-124711.html Ergomed notes Aeterna Zentaris drug trial results https://www.proactiveinvestors.com/companies/news/177155/ergomed-notes-aeterna-zentaris-drug-trial-results-177155.html Tue, 02 May 2017 09:23:00 -0400 https://www.proactiveinvestors.com/companies/news/177155/ergomed-notes-aeterna-zentaris-drug-trial-results-177155.html Boardroom reshuffle at Ergomed https://www.proactiveinvestors.com/companies/news/176421/boardroom-reshuffle-at-ergomed-176421.html Thu, 13 Apr 2017 06:24:00 -0400 https://www.proactiveinvestors.com/companies/news/176421/boardroom-reshuffle-at-ergomed-176421.html Ergomed chairman buys 100,000 shares https://www.proactiveinvestors.com/companies/news/175932/ergomed-chairman-buys-100000-shares-175932.html Tue, 04 Apr 2017 12:17:00 -0400 https://www.proactiveinvestors.com/companies/news/175932/ergomed-chairman-buys-100000-shares-175932.html Drug research specialist Ergomed ready to push ahead with collaboration https://www.proactiveinvestors.com/companies/news/175820/drug-research-specialist-ergomed-ready-to-push-ahead-with-collaboration-175820.html Mon, 03 Apr 2017 07:24:00 -0400 https://www.proactiveinvestors.com/companies/news/175820/drug-research-specialist-ergomed-ready-to-push-ahead-with-collaboration-175820.html Ergomed revenues rise by almost a third as drug monitoring powers on https://www.proactiveinvestors.com/companies/news/175527/ergomed-revenues-rise-by-almost-a-third-as-drug-monitoring-powers-on-175527.html Tue, 28 Mar 2017 09:00:00 -0400 https://www.proactiveinvestors.com/companies/news/175527/ergomed-revenues-rise-by-almost-a-third-as-drug-monitoring-powers-on-175527.html Drug developer Ergomed set to kick off phase II trial on treatment for surgical bleeding https://www.proactiveinvestors.com/companies/news/175040/drug-developer-ergomed-set-to-kick-off-phase-ii-trial-on-treatment-for-surgical-bleeding-175040.html Mon, 20 Mar 2017 15:27:00 -0400 https://www.proactiveinvestors.com/companies/news/175040/drug-developer-ergomed-set-to-kick-off-phase-ii-trial-on-treatment-for-surgical-bleeding-175040.html Phase II Peprostat study 'a major milestone' says Ergomed's Andrew Mackie https://www.proactiveinvestors.com/companies/news/307131/phase-ii-peprostat-study-a-major-milestone-says-ergomed-s-andrew-mackie-7131.html Mon, 20 Mar 2017 15:18:00 -0400 https://www.proactiveinvestors.com/companies/news/307131/phase-ii-peprostat-study-a-major-milestone-says-ergomed-s-andrew-mackie-7131.html Ergomed boss runs Proactive through 'very good results' from Phase II trial for insomnia treatment https://www.proactiveinvestors.com/companies/news/306872/ergomed-boss-runs-proactive-through-very-good-results-from-phase-ii-trial-for-insomnia-treatment-6872.html Tue, 07 Feb 2017 13:19:00 -0500 https://www.proactiveinvestors.com/companies/news/306872/ergomed-boss-runs-proactive-through-very-good-results-from-phase-ii-trial-for-insomnia-treatment-6872.html Ergomed announces positive top-line results from Phase II insomnia treatment trial https://www.proactiveinvestors.com/companies/news/172685/ergomed-announces-positive-top-line-results-from-phase-ii-insomnia-treatment-trial-172685.html Mon, 06 Feb 2017 12:05:00 -0500 https://www.proactiveinvestors.com/companies/news/172685/ergomed-announces-positive-top-line-results-from-phase-ii-insomnia-treatment-trial-172685.html Ergomed expects 'pivotal ' endometrial cancer trial result in April https://www.proactiveinvestors.com/companies/news/172480/ergomed-expects-pivotal-endometrial-cancer-trial-result-in-april-172480.html Wed, 01 Feb 2017 16:01:00 -0500 https://www.proactiveinvestors.com/companies/news/172480/ergomed-expects-pivotal-endometrial-cancer-trial-result-in-april-172480.html Ergomed Plc hails strong revenue surge https://www.proactiveinvestors.com/companies/news/306744/ergomed-plc-hails-strong-revenue-surge-6744.html Tue, 17 Jan 2017 11:54:00 -0500 https://www.proactiveinvestors.com/companies/news/306744/ergomed-plc-hails-strong-revenue-surge-6744.html Ergomed predicts more to come as revenues surge https://www.proactiveinvestors.com/companies/news/171726/ergomed-predicts-more-to-come-as-revenues-surge-171726.html Tue, 17 Jan 2017 08:21:00 -0500 https://www.proactiveinvestors.com/companies/news/171726/ergomed-predicts-more-to-come-as-revenues-surge-171726.html PharmInvent acquisition 'consolidates Ergomed PLC's position in Europe https://www.proactiveinvestors.com/companies/news/306522/pharminvent-acquisition-consolidates-ergomed-plc-s-position-in-europe-6522.html Thu, 01 Dec 2016 14:00:00 -0500 https://www.proactiveinvestors.com/companies/news/306522/pharminvent-acquisition-consolidates-ergomed-plc-s-position-in-europe-6522.html Ergomed's PrimeVigilance unit bulks up with £6.8mln deal https://www.proactiveinvestors.com/companies/news/169654/ergomed-s-primevigilance-unit-bulks-up-with-68mln-deal-169654.html Tue, 29 Nov 2016 07:18:00 -0500 https://www.proactiveinvestors.com/companies/news/169654/ergomed-s-primevigilance-unit-bulks-up-with-68mln-deal-169654.html Ergomed names new chairman designate https://www.proactiveinvestors.com/companies/news/169245/ergomed-names-new-chairman-designate-169245.html Mon, 21 Nov 2016 07:45:00 -0500 https://www.proactiveinvestors.com/companies/news/169245/ergomed-names-new-chairman-designate-169245.html Expansion of Modus study 'great news for Ergomed Plc' https://www.proactiveinvestors.com/companies/news/306406/expansion-of-modus-study-great-news-for-ergomed-plc--6406.html Wed, 16 Nov 2016 16:02:00 -0500 https://www.proactiveinvestors.com/companies/news/306406/expansion-of-modus-study-great-news-for-ergomed-plc--6406.html Ergomed welcomes expansion of Sickle Cell Disease study https://www.proactiveinvestors.com/companies/news/169054/ergomed-welcomes-expansion-of-sickle-cell-disease-study-169054.html Wed, 16 Nov 2016 07:26:00 -0500 https://www.proactiveinvestors.com/companies/news/169054/ergomed-welcomes-expansion-of-sickle-cell-disease-study-169054.html Ergomed racing away with development pipeline https://www.proactiveinvestors.com/companies/news/168610/ergomed-racing-away-with-development-pipeline-168610.html Mon, 07 Nov 2016 09:45:00 -0500 https://www.proactiveinvestors.com/companies/news/168610/ergomed-racing-away-with-development-pipeline-168610.html Ergomed to team up with Asarina Pharma in phase IIb trial https://www.proactiveinvestors.com/companies/news/168312/ergomed-to-team-up-with-asarina-pharma-in-phase-iib-trial-168312.html Tue, 01 Nov 2016 07:38:00 -0400 https://www.proactiveinvestors.com/companies/news/168312/ergomed-to-team-up-with-asarina-pharma-in-phase-iib-trial-168312.html Ergomed’s partner Modus Therapeautics set for stock market IPO https://www.proactiveinvestors.com/companies/news/167815/ergomeds-partner-modus-therapeautics-set-for-stock-market-ipo-167815.html Mon, 24 Oct 2016 06:52:00 -0400 https://www.proactiveinvestors.com/companies/news/167815/ergomeds-partner-modus-therapeautics-set-for-stock-market-ipo-167815.html Ergomed celebrating fourth licensing deal for cancer drug Zoptrex https://www.proactiveinvestors.com/companies/news/306196/ergomed-celebrating-fourth-licensing-deal-for-cancer-drug-zoptrex-6196.html Mon, 17 Oct 2016 12:21:00 -0400 https://www.proactiveinvestors.com/companies/news/306196/ergomed-celebrating-fourth-licensing-deal-for-cancer-drug-zoptrex-6196.html Ergomed celebrates fourth licensing deal for anti-cancer compound https://www.proactiveinvestors.com/companies/news/167411/ergomed-celebrates-fourth-licensing-deal-for-anti-cancer-compound-167411.html Fri, 14 Oct 2016 06:26:00 -0400 https://www.proactiveinvestors.com/companies/news/167411/ergomed-celebrates-fourth-licensing-deal-for-anti-cancer-compound-167411.html Ergomed sees continued growth in Primevigilance after strong half https://www.proactiveinvestors.com/companies/news/306076/ergomed-sees-continued-growth-in-primevigilance-after-strong-half-6076.html Thu, 29 Sep 2016 15:13:00 -0400 https://www.proactiveinvestors.com/companies/news/306076/ergomed-sees-continued-growth-in-primevigilance-after-strong-half-6076.html Ergomed upbeat as drug safety arm powers ahead https://www.proactiveinvestors.com/companies/news/166444/ergomed-upbeat-as-drug-safety-arm-powers-ahead-166444.html Mon, 26 Sep 2016 14:52:00 -0400 https://www.proactiveinvestors.com/companies/news/166444/ergomed-upbeat-as-drug-safety-arm-powers-ahead-166444.html Ergomed picks up €1.5mln contract through German acquisitions https://www.proactiveinvestors.com/companies/news/166297/ergomed-picks-up-15mln-contract-through-german-acquisitions-166297.html Thu, 22 Sep 2016 07:05:00 -0400 https://www.proactiveinvestors.com/companies/news/166297/ergomed-picks-up-15mln-contract-through-german-acquisitions-166297.html Ergomed - German research house starts coverage with 'buy' https://www.proactiveinvestors.com/companies/news/166018/ergomed-german-research-house-starts-coverage-with-buy--166018.html Fri, 16 Sep 2016 13:16:00 -0400 https://www.proactiveinvestors.com/companies/news/166018/ergomed-german-research-house-starts-coverage-with-buy--166018.html Ergomed completes recruitment for insomnia drug trial https://www.proactiveinvestors.com/companies/news/163633/ergomed-completes-recruitment-for-insomnia-drug-trial-163633.html Thu, 08 Sep 2016 07:01:00 -0400 https://www.proactiveinvestors.com/companies/news/163633/ergomed-completes-recruitment-for-insomnia-drug-trial-163633.html Ergomed secures two new licensing deals for cancer compound https://www.proactiveinvestors.com/companies/news/147631/ergomed-secures-two-new-licensing-deals-for-cancer-compound-147631.html Fri, 02 Sep 2016 06:32:00 -0400 https://www.proactiveinvestors.com/companies/news/147631/ergomed-secures-two-new-licensing-deals-for-cancer-compound-147631.html Ergomed unit Prime Vigilance opening the doors in Boston https://www.proactiveinvestors.com/companies/news/127525/ergomed-unit-prime-vigilance-opening-the-doors-in-boston-127525.html Mon, 27 Jun 2016 07:03:00 -0400 https://www.proactiveinvestors.com/companies/news/127525/ergomed-unit-prime-vigilance-opening-the-doors-in-boston-127525.html Ergomed strengthens services business with two bolt-ons https://www.proactiveinvestors.com/companies/news/127032/ergomed-strengthens-services-business-with-two-bolt-ons-127032.html Mon, 13 Jun 2016 06:52:00 -0400 https://www.proactiveinvestors.com/companies/news/127032/ergomed-strengthens-services-business-with-two-bolt-ons-127032.html Ergomed expanding via earnings-enhancing acquisitions https://www.proactiveinvestors.com/companies/news/304993/ergomed-expanding-via-earnings-enhancing-acquisitions-4993.html Thu, 05 May 2016 14:44:00 -0400 https://www.proactiveinvestors.com/companies/news/304993/ergomed-expanding-via-earnings-enhancing-acquisitions-4993.html Ergomed snaps up bleed halting specialist https://www.proactiveinvestors.com/companies/news/125548/ergomed-snaps-up-bleed-halting-specialist-125548.html Wed, 04 May 2016 12:37:00 -0400 https://www.proactiveinvestors.com/companies/news/125548/ergomed-snaps-up-bleed-halting-specialist-125548.html Ergomed CFO Stamp on acquisition trail https://www.proactiveinvestors.com/companies/news/304884/ergomed-cfo-stamp-on-acquisition-trail-4884.html Tue, 12 Apr 2016 14:16:00 -0400 https://www.proactiveinvestors.com/companies/news/304884/ergomed-cfo-stamp-on-acquisition-trail-4884.html Ergomed has booked 85% of this year's revenues already https://www.proactiveinvestors.com/companies/news/124665/ergomed-has-booked-85-of-this-year-s-revenues-already-124665.html Tue, 12 Apr 2016 06:31:00 -0400 https://www.proactiveinvestors.com/companies/news/124665/ergomed-has-booked-85-of-this-year-s-revenues-already-124665.html Ergomed CFO expects co-development deals before prelims in Q1 https://www.proactiveinvestors.com/companies/news/304602/ergomed-cfo-expects-co-development-deals-before-prelims-in-q1-4602.html Tue, 02 Feb 2016 08:08:00 -0500 https://www.proactiveinvestors.com/companies/news/304602/ergomed-cfo-expects-co-development-deals-before-prelims-in-q1-4602.html Ergomed eyes more drug deals as revenues rise https://www.proactiveinvestors.com/companies/news/121982/ergomed-eyes-more-drug-deals-as-revenues-rise-121982.html Mon, 01 Feb 2016 15:07:00 -0500 https://www.proactiveinvestors.com/companies/news/121982/ergomed-eyes-more-drug-deals-as-revenues-rise-121982.html New Ergomed finance chief sees substantial growth ahead https://www.proactiveinvestors.com/companies/news/304540/new-ergomed-finance-chief-sees-substantial-growth-ahead-4540.html Mon, 11 Jan 2016 10:54:00 -0500 https://www.proactiveinvestors.com/companies/news/304540/new-ergomed-finance-chief-sees-substantial-growth-ahead-4540.html Ergomed takes on former Shire man in finance role https://www.proactiveinvestors.com/companies/news/121152/ergomed-takes-on-former-shire-man-in-finance-role-121152.html Mon, 11 Jan 2016 08:21:00 -0500 https://www.proactiveinvestors.com/companies/news/121152/ergomed-takes-on-former-shire-man-in-finance-role-121152.html Ergomed building on drug development partnerships https://www.proactiveinvestors.com/companies/news/304495/ergomed-building-on-drug-development-partnerships-4495.html Thu, 17 Dec 2015 08:28:00 -0500 https://www.proactiveinvestors.com/companies/news/304495/ergomed-building-on-drug-development-partnerships-4495.html Ergomed partnerships making progress https://www.proactiveinvestors.com/companies/news/120519/ergomed-partnerships-making-progress-120519.html Wed, 16 Dec 2015 07:57:00 -0500 https://www.proactiveinvestors.com/companies/news/120519/ergomed-partnerships-making-progress-120519.html UPDATE - Ergomed unfazed by cancer trial end https://www.proactiveinvestors.com/companies/news/116475/update-ergomed-unfazed-by-cancer-trial-end-116475.html Wed, 21 Oct 2015 15:03:00 -0400 https://www.proactiveinvestors.com/companies/news/116475/update-ergomed-unfazed-by-cancer-trial-end-116475.html Ergomed partner given green light to continue cancer study https://www.proactiveinvestors.com/companies/news/116192/ergomed-partner-given-green-light-to-continue-cancer-study-116192.html Wed, 14 Oct 2015 06:34:00 -0400 https://www.proactiveinvestors.com/companies/news/116192/ergomed-partner-given-green-light-to-continue-cancer-study-116192.html Ergomed says sickle-cell drug enters proof-of-concept study https://www.proactiveinvestors.com/companies/news/116147/ergomed-says-sickle-cell-drug-enters-proof-of-concept-study-116147.html Tue, 13 Oct 2015 07:17:00 -0400 https://www.proactiveinvestors.com/companies/news/116147/ergomed-says-sickle-cell-drug-enters-proof-of-concept-study-116147.html Ergomed increases backing for Multikine cancer treatment https://www.proactiveinvestors.com/companies/news/114353/ergomed-increases-backing-for-multikine-cancer-treatment-114353.html Mon, 05 Oct 2015 12:44:00 -0400 https://www.proactiveinvestors.com/companies/news/114353/ergomed-increases-backing-for-multikine-cancer-treatment-114353.html Ergomed eyeing up more co-development deals https://www.proactiveinvestors.com/companies/news/304194/ergomed-eyeing-up-more-co-development-deals-4194.html Tue, 29 Sep 2015 15:05:00 -0400 https://www.proactiveinvestors.com/companies/news/304194/ergomed-eyeing-up-more-co-development-deals-4194.html UPDATE - Ergomed orders grow strongly as it weighs in with solid set of interims https://www.proactiveinvestors.com/companies/news/111213/update-ergomed-orders-grow-strongly-as-it-weighs-in-with-solid-set-of-interims-111213.html Tue, 29 Sep 2015 13:31:00 -0400 https://www.proactiveinvestors.com/companies/news/111213/update-ergomed-orders-grow-strongly-as-it-weighs-in-with-solid-set-of-interims-111213.html Ergomed named finalist at Scrip awards https://www.proactiveinvestors.com/companies/news/111051/ergomed-named-finalist-at-scrip-awards-111051.html Wed, 23 Sep 2015 08:51:00 -0400 https://www.proactiveinvestors.com/companies/news/111051/ergomed-named-finalist-at-scrip-awards-111051.html Ergomed points to new milestone for co-development partner https://www.proactiveinvestors.com/companies/news/109964/ergomed-points-to-new-milestone-for-co-development-partner-109964.html Fri, 14 Aug 2015 06:49:00 -0400 https://www.proactiveinvestors.com/companies/news/109964/ergomed-points-to-new-milestone-for-co-development-partner-109964.html Ergomed announces first patient has been recruited for insomnia study https://www.proactiveinvestors.com/companies/news/108978/ergomed-announces-first-patient-has-been-recruited-for-insomnia-study-108978.html Tue, 14 Jul 2015 09:35:00 -0400 https://www.proactiveinvestors.com/companies/news/108978/ergomed-announces-first-patient-has-been-recruited-for-insomnia-study-108978.html Ergomed appoints familiar face as chief business officer https://www.proactiveinvestors.com/companies/news/108618/ergomed-appoints-familiar-face-as-chief-business-officer-108618.html Thu, 02 Jul 2015 07:23:00 -0400 https://www.proactiveinvestors.com/companies/news/108618/ergomed-appoints-familiar-face-as-chief-business-officer-108618.html Ergomed chosen to conduct growth hormone study https://www.proactiveinvestors.com/companies/news/108402/ergomed-chosen-to-conduct-growth-hormone-study-108402.html Thu, 25 Jun 2015 13:10:00 -0400 https://www.proactiveinvestors.com/companies/news/108402/ergomed-chosen-to-conduct-growth-hormone-study-108402.html Ergomed acquires medical information firm Sound Opinion https://www.proactiveinvestors.com/companies/news/107321/ergomed-acquires-medical-information-firm-sound-opinion-107321.html Tue, 26 May 2015 06:26:00 -0400 https://www.proactiveinvestors.com/companies/news/107321/ergomed-acquires-medical-information-firm-sound-opinion-107321.html UK life science sector offers rich vein for investors - Stifel https://www.proactiveinvestors.com/companies/news/106883/uk-life-science-sector-offers-rich-vein-for-investors-stifel-106883.html Mon, 18 May 2015 12:39:00 -0400 https://www.proactiveinvestors.com/companies/news/106883/uk-life-science-sector-offers-rich-vein-for-investors-stifel-106883.html Ergomed CEO says acquisition strategy should demand higher share price https://www.proactiveinvestors.com/companies/news/303768/ergomed-ceo-says-acquisition-strategy-should-demand-higher-share-price-3768.html Thu, 14 May 2015 11:07:00 -0400 https://www.proactiveinvestors.com/companies/news/303768/ergomed-ceo-says-acquisition-strategy-should-demand-higher-share-price-3768.html UPDATE - Ergomed and partner receive safety green light for new cancer drug https://www.proactiveinvestors.com/companies/news/68510/update-ergomed-and-partner-receive-safety-green-light-for-new-cancer-drug--79795.html Wed, 29 Apr 2015 12:18:00 -0400 https://www.proactiveinvestors.com/companies/news/68510/update-ergomed-and-partner-receive-safety-green-light-for-new-cancer-drug--79795.html Ergomed well-placed with strong backlog of signed contracts https://www.proactiveinvestors.com/companies/news/67436/ergomed-well-placed-with-strong-backlog-of-signed-contracts-78636.html Wed, 25 Mar 2015 07:21:00 -0400 https://www.proactiveinvestors.com/companies/news/67436/ergomed-well-placed-with-strong-backlog-of-signed-contracts-78636.html UPDATE - Ergomed opens first office in Asia https://www.proactiveinvestors.com/companies/news/67341/update-ergomed-opens-first-office-in-asia-78537.html Mon, 23 Mar 2015 14:04:00 -0400 https://www.proactiveinvestors.com/companies/news/67341/update-ergomed-opens-first-office-in-asia-78537.html Ergomed experts get invite to prestigious US event https://www.proactiveinvestors.com/companies/news/67095/ergomed-experts-get-invite-to-prestigious-us-event-78268.html Mon, 16 Mar 2015 06:37:00 -0400 https://www.proactiveinvestors.com/companies/news/67095/ergomed-experts-get-invite-to-prestigious-us-event-78268.html Ergomed signs joint development deal with Sweden's Dilaforette https://www.proactiveinvestors.com/companies/news/303055/ergomed-signs-joint-development-deal-with-swedens-dilaforette--3502.html Thu, 19 Feb 2015 12:49:00 -0500 https://www.proactiveinvestors.com/companies/news/303055/ergomed-signs-joint-development-deal-with-swedens-dilaforette--3502.html Ergomed sickle-cell joint development deal will see it take stake in partner https://www.proactiveinvestors.com/companies/news/66351/ergomed-sickle-cell-joint-development-deal-will-see-it-take-stake-in-partner-77442.html Ergomed has agreed to co-develop a drug in a deal that will see it receive a stake in its partner, Sweden’s Dilaforette.

]]>
Thu, 19 Feb 2015 06:29:00 -0500 https://www.proactiveinvestors.com/companies/news/66351/ergomed-sickle-cell-joint-development-deal-will-see-it-take-stake-in-partner-77442.html
Ergomed well placed with strong order book - CFO https://www.proactiveinvestors.com/companies/news/302987/ergomed-well-placed-with-strong-order-book-cfo-3423.html Wed, 21 Jan 2015 09:28:00 -0500 https://www.proactiveinvestors.com/companies/news/302987/ergomed-well-placed-with-strong-order-book-cfo-3423.html Ergomed reveals 40% spike in orders in the second half of 2014 https://www.proactiveinvestors.com/companies/news/65416/ergomed-reveals-40-spike-in-orders-in-the-second-half-of-2014-76385.html Ergomed, the pharma services business that also co-develops drugs, said it saw a sharp spike in order intake in the second half last year.

]]>
Tue, 20 Jan 2015 12:02:00 -0500 https://www.proactiveinvestors.com/companies/news/65416/ergomed-reveals-40-spike-in-orders-in-the-second-half-of-2014-76385.html
Ergomed (LON:ERGO) - Investor Presentation January 15th 2015 https://www.proactiveinvestors.com/companies/news/302973/ Fri, 16 Jan 2015 07:36:00 -0500 https://www.proactiveinvestors.com/companies/news/302973/ Ergomed, Silence Therapeutics, Symphony Environmental Technologies at next forum https://www.proactiveinvestors.com/companies/news/65163/ergomed-silence-therapeutics-symphony-environmental-technologies-at-next-forum-76092.html Next Thursday we would be delighted if you could join us in Mayfair to hear from three fantastic AIM companies - Silence Therapeutics (LON:SLN),  Symphony Environmental Technologies (LON:SYM) and Ergomed (LON:ERGO).

]]>
Fri, 09 Jan 2015 16:30:00 -0500 https://www.proactiveinvestors.com/companies/news/65163/ergomed-silence-therapeutics-symphony-environmental-technologies-at-next-forum-76092.html
Ergomed boosted by cancer drug licensing deal in China https://www.proactiveinvestors.com/companies/news/64319/ergomed-boosted-by-cancer-drug-licensing-deal-in-china-75148.html Mon, 08 Dec 2014 09:15:00 -0500 https://www.proactiveinvestors.com/companies/news/64319/ergomed-boosted-by-cancer-drug-licensing-deal-in-china-75148.html Co-development the key as Ergomed strives for biotech big time https://www.proactiveinvestors.com/companies/news/63685/co-development-the-key-as-ergomed-strives-for-biotech-big-time-74418.html Ergomed’s strategy is to invest its valuable time and research expertise in helping a fledgling biotech through the tricky and expensive stages of development.

]]>
Mon, 17 Nov 2014 10:00:00 -0500 https://www.proactiveinvestors.com/companies/news/63685/co-development-the-key-as-ergomed-strives-for-biotech-big-time-74418.html